Fasila Razzia Gaffar

Title: The Innovative Contributions of Fasila Razzia Gaffar

Introduction

Fasila Razzia Gaffar is a notable inventor based in Amsterdam, Netherlands. She has made significant contributions to the field of biotechnology, particularly in vaccine development. With a total of 2 patents, her work is paving the way for advancements in immunology.

Latest Patents

One of her latest patents is focused on a Piroplasmid vaccine. This invention relates to a Piroplasmid protein or an immunogenic fragment of the protein, along with a nucleic acid encoding the Piroplasmid protein or immunogenic fragment. The patent also covers cDNA fragments, recombinant DNA molecules, and live recombinant carriers that comprise the nucleic acid. Additionally, it includes host cells that contain these cDNA fragments and recombinant DNA molecules. The invention further extends to vaccines that utilize a Piroplasmid protein or its immunogenic fragments, methods for preparing such vaccines, and their use in diagnostic tests.

Career Highlights

Fasila Razzia Gaffar is associated with Universiteit Utrecht Holding B.V., where she continues to innovate and contribute to her field. Her work is characterized by a strong focus on developing effective vaccines that can address various health challenges.

Collaborations

Throughout her career, Fasila has collaborated with esteemed colleagues, including Erik De Vries and Ana Patricia Yatsuda. These collaborations have enhanced her research and contributed to the successful development of her patents.

Conclusion

Fasila Razzia Gaffar's contributions to vaccine development through her innovative patents highlight her role as a leading inventor in biotechnology. Her work not only advances scientific knowledge but also has the potential to impact public health positively.